Recently, Savage et al. indicated that Treg cell-derived AREG promotes glucose intolerance in a NASH-dependent manner through EGFR signaling and IL-6, which is consistent with our hypothesis (23). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.